Introduction

E
uropean Union (EU) law guarantees that every citizen is entitled to preventive healthcare and medical treatment. 1 However, healthcare is an area in which the EU has limited power, i.e. due to the subsidiarity principle, the competencies remain mainly within the Member-States. Nevertheless, EU citizens have demanded the right to freely access other EU health systems since the end of the 90s, which was warranted by decisions of the European Court of Justice. 2 As a result, the negotiations began for the future Directive 2011/24/EU on patients' rights in cross-border healthcare.
Before 2011 the movement of EU patients to receive healthcare in another EU country (also known as cross-border patient mobility) accounted for more than 9.7 billion Euros in healthcare spending per year. 3 The cross-border patient mobility at that time was mainly due to unplanned care or referrals to other EU healthcare systems by national providers. Indeed, the cross-border patient mobility can be planned, for instance, if the patient deliberately travel across the border to obtain healthcare, or unplanned, 4, 5 as shown in table 1. The relevance of cross-border patient mobility is based on the assumption that the redistribution of supply and demand could lead to improved safety, quality and efficiency. [6] [7] [8] [9] [10] Many authors have sought to describe the barriers and facilitators to cross-border patient mobility, namely, the proximity of cross-border services (geographical and those related to language), perceived quality of care, affordability, 4, 11 range of the basket of care 12, 13 and responsiveness. 14 Approved in 2011 and transposed to the national law of member states in 2013, the Directive 2011/24/EU on patients' rights in crossborder facilitated cross-border healthcare healthcare, although it did not create new entitlements, the Directive clarified the rights of patients to seek reimbursement for healthcare received in another Member-State. 15 Simply stated, an EU citizen who goes to another country to purchase healthcare available in his home country should be covered by the home-country health insurance. The clarification of the entitlements made the reimbursement of health expenses in another Member-State more predictable and clarified the basket of care in the EU countries. [16] [17] [18] However, some restrictions in the Directive were implemented, i.e. prior authorisations for hospitalisations that require an overnight stay and highly specialised, cost-intensive healthcare. On top of that, some countries required slightly different prior authorisation procedures. 19, 20 This complex navigation framework can act by itself as a barrier to cross-border patient mobility.
To the best of our knowledge, no study has measured how patients (and which patients) may have changed their willingness to travel for healthcare following the implementation of the Directive. In this study, we measured the cross-patient mobility and its determinants before and after the implementation of the Directive. By doing so, we expect to highlight the extent to which the Directive has been successful in enhancing patient mobility across Europe, while the analysis of determinants will help identify which sub-populations should be targeted to improve the mobility patterns.
Methods
Data sources and study design
We used primary data from the flash Eurobarometer 210 (2007) 21 and the special Eurobarometer 425 (2014) 22 obtained through the Leibniz-Institute for the Social Sciences (GESIS). The
Eurobarometer's repeated cross-section surveys covered participants from the EU Member-States, and each national sample was representative of the population aged 15 years and over. Participants were sampled using a multistage random sampling design based on country-specific population size. In 2007, the mode of data collection was mainly through computerised assisted telephone interviews (70% of the sample) and the rest were face-to-face interview. For 2014, the mode of data collection was only face-toface interview by computer assisted personal interviews. All variables were self-reported. The interviewer indicated the Country of residence; the study team recoded West and East-Germany into Germany and England and Northern Ireland into the UK. Detailed methods of the surveys' methodology can be found elsewhere. 23 The European Commission was responsible for the approval of the study protocols, and informed consent was obtained from all participants. The information was anonymised and de-identified before analysis.
Study outcomes
We studied two main outcomes: (i) if the participants had received medical care outside of their residency country over the 12 months preceding the interview, hereinafter called 'cross-border patient mobility' and (ii) if the participants were willing to travel to another EU state to receive medical care, hereinafter called 'willingness to travel'. The questions related to these outcomes were asked in the same way as in both Eurobarometer 210 (2007) and 425 (2014) 'Have you received any medical treatment in another EU country in the last 12 months?'. The 'cross-border patient mobility' was coded as a binary variable, 'yes' or 'no'. The question on willingness to travel, 'Would you be willing to travel to another EU country to receive medical treatment?', included three responses, 'yes', 'no' and 'depends'. We coded the willingness to travel for healthcare as a binary variable, assimilating the 'depends' answer to an affirmative answer.
Explanatory variables
Age, gender, education, employment status and country size were included as explanatory variables, following earlier contributions on patient mobility. 6, 5, 24 Age was measured in years and used as a continuous variable; however, to facilitate the interpretation, the odds ratio (OR) was presented in 10-year intervals. Education was a three-category variable, which indicated the age at which the person concluded her/his education: 'less than 15 years old', 'more than 15 years-old' or 'still studying'. Employment status was divided into 'working', 'retired' and 'not working' (unemployed and students) categories. The country size was defined as the population size weight of the country based on the resident population, used by the Eurobarometer Survey, and the countries were then aggregated in population weight tertiles (large, medium and small countries). As there is no consensus about the definition of country sizes in the EU we decided to use population weights tertiles as a cut-off measure.
Sensitivity analysis
First, to account for potential misclassification of the 'willingness to travel' variable related to the decision to classify respondents who answered 'depends' as willing to travel, we replicated the models classifying people answering 'depends' as not willing to travel. Second, to address the possible confounding effect attributable to not having information about health status, we used the bad and very bad self-perceived health (SPH) data from the European Survey on Income and Living Conditions (EU-SILC) for the years 2007 and 2014. We calculated the prevalence of 'bad' and 'very bad' SPH by country, age group, gender and employment status. This aggregate determinant was attributed to each observation from the Eurobarometer according to its country, age group, gender and employment status. The models were replicated adjusting for this group-specific prevalence of bad and very bad SPH.
Statistical methods
We used Chi-square tests to compare frequency distributions for categorical variables, and t-tests were used to compare the means of continuous variables (age). All proportions and means were weighted according to sampling weights.
We then pooled the data for 2007 and 2014 and performed a logistic regression on the cross-border patient mobility and willingness to travel to other EU countries. We modelled these outcomes as a function of the year (2007 or 2014), age, gender, education and country size.
Age was tested in the model in square root, quadratic and cubic function to check for non-linear behaviour. The missing data were not incorporated into the models. The population size weighting factors correct for the fact that most countries have almost identical sample sizes (n = 1000), no matter how large or small their populations are, these weights were applied to determine percentages in descriptive analysis and in the multivariate analyses.
For the statistical analysis, we used Stata 13.
Results
The sample included 55 096 observations from all EU countries. After elimination of observations with missing data, the sample was reduced to 53 439 observations (3% of the sample was removed), distributed by 48.2% of the respondents in 2007 and 51.8% in 2014. Table 2 shows the baseline characteristics of the population. The mean age is 48 years old and 56% are female. More than half of the interviewed were working, and 77% were from large European countries. Overall, interviewees who received medical care abroad (cross-border patient mobility) were younger (mean age 45.3 years), more likely to be male (4.5 vs. 3.5% in women), more educated (4.6 vs. 3.5% stopped studying after 15 years old). Also, retired individuals (3.3 vs. 4.4% working) and those from large countries (3.0 vs. 4.4% in small countries) received less medical care abroad. A very similar pattern was observed for the willingness to travel. 
Cross-border patient mobility
Considering the whole sample, 4.0% engaged in cross-border patient mobility, which increased from 3.3% in 2007 to 4.6% in 2014. Nevertheless, the absolute values remained low. In the unadjusted analysis, some factors favoured the cross-border patient mobility, among which gender and education were the most notable (table 3) . In the adjusted analysis, males had a 19% increased likelihood of crossing borders when compared with women (OR 1.19 95% confidence interval (CI) 1.08-1.30). The EU citizens who stopped studying at age 15 years old or older had a 20% greater likelihood of cross-border patient mobility (OR 1.20 95% CI 1.09-1.31), when compared with those who stopped at 15 years old or younger. In the year 2014, there was an 11% increase in the likelihood of having received medical care abroad when compared with the year 2007 (OR 1.11 95% CI 1.02-1.21).
However, some determinants seem to hinder the cross-border patient mobility, corresponding to: older age, with an 11% decrease in the odds per decade (OR 0.89, 95% CI 0.85-0.93) and being from a medium (OR 0.84 95% CI 0.76-0.93) or large country (OR 0.78 95% CI 0.65-0.93). The employment and student status lost their significance in the adjusted model.
Willingness to travel to receive medical care
The willingness to travel to receive medical care fell from 2007 to 2014. Contrasting with the cross-border patient mobility low prevalence, the percentage of citizens willing to travel is high, 55.0% in 2007 and 48.5% in 2014. In 2014, 3.2% stated willingness to travel to receive healthcare would depend on the country's provision of care, and 12.7% said it would depend on the type of treatment (data not shown in tables).
In the unadjusted model, the willingness to travel was significantly and positively associated with being male, more educated, in school and not working, while a significant negative association was
In the adjusted model, the determinants that favoured the willingness to travel were being male (OR 1.07, 95% CI 1.01-1.08), being a non-worker (OR 1.07 95% CI 1.05-1.20), having stopped studying at 15 years or older (OR 1.32 95% CI 1.26-1.37) and being from a large country (OR 1.54 95% CI 1.43-1.66) (table 4) .
Some determinants in the adjusted model were barriers to the willingness to travel to receive medical care, such as older age ( 
Sensitivity analysis
In the model in which we categorised the 'depends' response as not willing to travel, the signal and significance of the year estimate were not altered. However, the 2014 reduction in willingness to travel changed from À20 to À59% (Supplementary table S1 ).
After the adjustment for self-reported health, most point estimates remained stable in significance and magnitude, namely year, age and gender. The significant major change was that people from large countries reported a lower willingness to travel, contrary to the model without self-reported health (Supplementary table S1).
Discussion
Key findings
We conducted a study seeking to identify the determinants of crossborder patient mobility and the willingness to travel to receive medical care in the EU using data from interviews of two Eurobarometer surveys. We found that between 2007 and 2014 there was an increase in cross-border mobility (+15%) and a decrease in willingness to travel to receive medical care (À20%). This decrease was much more pronounced when people who answered 'depends' on the willingness to travel question were classified as not willing to travel (À59%). Additionally, older people were less likely to seek medical care across the border (À11% per decade) and less willing to receive medical care in another EU country (À14% per decade). More educated EU citizens were more likely to seek healthcare abroad (+20%) and more willing to travel to receive care (+32%). The larger the country of residence, the less likely the use of cross-border medical care. Furthermore, men engaged more in cross-border medical care (+20%) and were more likely to be willing to seek medical care in another EU country (+7%).
Interpretation
The literature that compares cross-border mobility or willingness to travel in the EU is scarce. In a small survey in Malta, Busuttil et al. 25 found similar determinants of willingness to travel. Also, there are no other regions of the globe with similar cross-border healthcare frameworks. For the USA, estimates of planned cross-border patient mobility vary between 1 and 1.5%, 26 although it can go up to 37% in the Mexican border region. 27 Regarding the determinants of cross-border mobility and willingness to travel, one could hypothesise that younger patients are more likely to cross a border to seek medical care due to their greater facility to overcome some barriers such as language, as most younger people can communicate in a common language (English). 28, 29 The learning-by-doing effect might play a role as well, i.e. younger people who have already travelled to another Member-State for other purposes (e.g. Erasmus and DaVinci programmes) may be more likely to have experienced a foreign health system within the EU, 30 thereby being keener to engage in cross-border patient mobility.
To the best of our knowledge, the greater likelihood of males to travel for care has never been documented. We know, however, that men are also more likely (22%) to envisage working abroad in the EU, possibly in line with our results. 31 Higher levels of education are not a surprising determinant of cross-border patient mobility and willingness to travel. More years of education entail a better understanding of rights and more demanding expectations of the healthcare system. 25, 32 Interestingly, employment status does not play a role in crossborder patient mobility. Working people with a steady income were expected to be more likely to be able to afford travel for care. However, our employment categories were possibly too broad and heterogeneous to capture differences in socio-economic conditions. The 'employed' category, in particular, may encompass very different occupations, social positions and incomes. It is surprising, however, that individuals not working would be more likely to be willing to travel for care. The not working condition may be associated with unmeasured health problems, possibly explaining this finding. Moreover, working individuals might find more difficult to take days off than non-workers to travel abroad.
The greater mobility by people from smaller countries may be explained by the possibly lower provision of highly specialised care, which is more profitable in large countries facing a greater demand. 33 People in smaller countries also face lower travel distance to reach a neighbouring country. The most obvious example is Luxembourg, where 18% of people seek care abroad. 22 The distance explanation may be the most plausible, as we observe that people from larger countries are more willing to travel but less likely to do so. In other terms, people from larger countries may also face unmet needs creating a willingness to travel, which is not satisfied because of geographical barriers.
The increase in mobility combined with a decrease in the willingness to travel could mean that some unmet needs were covered by seeking medical care abroad. Some authors claim that cross-border patient mobility could redistribute supply and demand towards a better provision of care regarding safety, quality and efficiency. 2 Also, the decrease in the willingness to travel to seek care abroad could mean that unmet needs within the country were reduced following the Directive. Indeed, some literature reports that the Directive was an opportunity to implement reforms 10 including legislation on patients' rights, 16 ,17 the definition of health benefits package and compulsory indemnity insurance, however, although with variations across countries, 34 it seems thus that the Directive had positive spillovers.
Despite the 1.3 percentage point increase in cross-border patient mobility in 2014, the absolute numbers remain low. Even with the implementation of the Directive, we are far from a dynamic EU health market. In the process of engaging in cross-border patient mobility, the willingness to travel is the first stage. One could consider the willingness to travel as the maximum stock of the population that may travel; therefore, only a 10th of those who are willing to travel actually engage in cross-border patient mobility. The small relative increase in the recent years could be influenced by the financial, economic and social crisis in Europe. Cross-border mobility under the new Directive demands considerable out-of-pocket expenditures because the reimbursement of expenses is done after the provision of services. Adverse economic circumstances could, thus, have a negative impact on cross-border patient mobility. However, cross-border mobility to countries where the cost of care is significantly lower must always be considered as a potential motivation, despite all the barriers. Time may also play an important role, since the Directive came into force only 1 year before the second survey, giving little time for the information to permeate into health systems and to the general public knowledge.
Strengths and limitations
This study is to the best of our knowledge the first to quantify the determinants of cross-border patient mobility and the willingness to travel to receive medical care, at the EU level. We were able to demonstrate empirically what was earlier theorised, 4 that citizens from larger countries, which can concentrate more healthcare resources are less likely to seek medical care abroad.
This study has some limitations. First, the surveys in 2007 and 2014 had some differences in the methodology applied. In 2007, the survey used mainly telephone interviews, which might lead to some selection bias towards participants who spend more time at home (retired, unemployed), with a lower purchasing power, and therefore less likely to seek medical care abroad. In 2014, all interviews were done face-to-face. These different methods might overestimate the difference in cross-border mobility between the 2 years. Although this might affect the estimate of the 'Year' determinant, it is unlikely to influence the other determinants.
Also, the causal pathway from socio-demographic determinants to cross-border mobility could not be adequately assessed, which would require information about unmet medical needs, affordability of care and perceived medical quality. However, our study was a first assessment of determinants of cross-border mobility, distinguishing which sub-populations travel or are willing to travel. This is valuable information for decision-making, although more detailed surveys are necessary for a complete understanding of the phenomenon.
Another limitation is related to the inability to stratify patient mobility into planned and unplanned. In the 2014 survey, this stratification was possible but in 2007 the stratified data were not available. That could be seen as a limitation because planned and unplanned medical care might have different determinants. Hence, planned or unplanned care might act as an effect modifier. The European Commission reports that $40% of all the cross-border patient mobility is planned.
Future research
One of the most exciting aspects to study in the future is the relationship between health condition, unmet needs, cross-border patient mobility and the willingness to seek medical care abroad. Whether the current EU legislation effectively protects the EU citizens from constraints in the country health systems generating unmet needs is unknown.
Conclusion
Our study demonstrates that being younger, male, more educated and from a small country increases the likelihood of engaging in cross-border patient mobility and that this mobility, although remaining at very low levels, increased in Europe between 2007 and 2014, following the implementation of the patients' rights in cross-border healthcare Directive. The weak and socially patterned rate of cross-border patient mobility indicates that we are far from a European healthcare market, whose potential benefits are within reach. Policy-makers should consider changes to promote the directive among European decision-makers and populations, with a particular focus on the neediest and most vulnerable.
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